Veloxis Pharmaceuticals
Presence
Asahi Kasei is one of the...
Asahi Kasei is a company listed under the stock ticker 3407 (JP).
Asahi Kasei has a direct presence in 10 countries.Asahi Kasei has 23 subsidiaries including Asahi Kasei Construction, Asahi Kasei Homes and Asahi Kasei Medical.
They are in:
- Medical Equipment29%
- Chemicals13%
- Other58%
Executives
View the org chart displaying its 14 main executives
Most searched biographies at Veloxis Pharmaceuticals
- Mark Hensley, Chief Executive Officer
- Ed Sleeper, Chief Ethics and Compliance Officer
- Ulf Meier-Kriesche, Chief Scientific Officer
Create your alert
to follow the executive moves at Veloxis Pharmaceuticals.
Pharmaceuticals
Asahi Kasei has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Veloxis Pharmaceuticals
- News | Veloxis Pharmaceuticals Chief Scientific Officer to Receive National Kidney Foundation’s Market Innovation Award
- Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark offentliggør det foreløbige resultat af samt afslutningen på dets offentlige købstilbud på aktier og warrants i Veloxis Pharmaceuticals | Veloxis Pharmaceuticals
- Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020 | Veloxis Pharmaceuticals
- Offentliggørelse af Nasdaq Copenhagen A/S' Accept af Veloxis Pharmaceuticals A/S' Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S | Veloxis Pharmaceuticals
- Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Konkurrencegodkendelser opnået for Asahi Kasei Pharma Denmarks offentlige overtagelsestilbud for aktier og warrants i Veloxis Pharmaceuticals | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Påmindelse om deadline for accept af Asahi Kasei Pharma Denmarks offentlige overtagelsestilbud | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Reminder of Approaching Deadline for the Acceptance of the Public Tender Offer by Asahi Kasei Pharma Denmark | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Competition approvals obtained for the public tender offer by Asahi Kasei Pharma Denmark for the shares and warrants in Veloxis Pharmaceuticals | Veloxis Pharmaceuticals
- View more press releases Close
Social media about Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Veloxis Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Mark Hensley 
Call Veloxis Pharmaceuticals at +45 ...
